(2R)-N-[(1-aminoisoquinolin-6-yl)methyl]-5-butoxy-2-[(3,4-difluorophenyl)methyl]-4-oxopentanamide;methane

C27H33F2N3O3 — CID 167582278

IUPAC(2R)-N-[(1-aminoisoquinolin-6-yl)methyl]-5-butoxy-2-[(3,4-difluorophenyl)methyl]-4-oxopentanamide;methane
SMILESC.CCCCOCC(=O)C[C@@H](Cc1ccc(F)c(F)c1)C(=O)NCc1ccc2c(N)nccc2c1
InChIInChI=1S/C26H29F2N3O3.CH4/c1-2-3-10-34-16-21(32)14-20(11-17-5-7-23(27)24(28)13-17)26(33)31-15-18-4-6-22-19(12-18)8-9-30-25(22)29;/h4-9,12-13,20H,2-3,10-11,14-16H2,1H3,(H2,29,30)(H,31,33);1H4/t20-;/m1./s1
InChIKeyHIHXSGYAIBUSBK-VEIFNGETSA-N
MW485.58 g/mol
LogP4.98
Rot. Bonds12

About (2R)-N-[(1-aminoisoquinolin-6-yl)methyl]-5-butoxy-2-[(3,4-difluorophenyl)methyl]-4-oxopentanamide;methane

(2R)-N-[(1-aminoisoquinolin-6-yl)methyl]-5-butoxy-2-[(3,4-difluorophenyl)methyl]-4-oxopentanamide;methane (PubChem CID 167582278) has the molecular formula C27H33F2N3O3 and a molecular weight of 485.58 g/mol. Its IUPAC name is (2R)-N-[(1-aminoisoquinolin-6-yl)methyl]-5-butoxy-2-[(3,4-difluorophenyl)methyl]-4-oxopentanamide;methane.

Molecular Properties

Compound Name(2R)-N-[(1-aminoisoquinolin-6-yl)methyl]-5-butoxy-2-[(3,4-difluorophenyl)methyl]-4-oxopentanamide;methane
PubChem CID167582278
Molecular FormulaC27H33F2N3O3
Molecular Weight485.58 g/mol
Exact Mass485.25
IUPAC Name(2R)-N-[(1-aminoisoquinolin-6-yl)methyl]-5-butoxy-2-[(3,4-difluorophenyl)methyl]-4-oxopentanamide;methane
SMILESC.CCCCOCC(=O)C[C@@H](Cc1ccc(F)c(F)c1)C(=O)NCc1ccc2c(N)nccc2c1
InChIInChI=1S/C26H29F2N3O3.CH4/c1-2-3-10-34-16-21(32)14-20(11-17-5-7-23(27)24(28)13-17)26(33)31-15-18-4-6-22-19(12-18)8-9-30-25(22)29;/h4-9,12-13,20H,2-3,10-11,14-16H2,1H3,(H2,29,30)(H,31,33);1H4/t20-;/m1./s1
InChIKeyHIHXSGYAIBUSBK-VEIFNGETSA-N
XLogP4.98
TPSA94.31 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds12
Heavy Atoms35
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500485.58
LogP ≤ 54.98
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (2R)-N-[(1-aminoisoquinolin-6-yl)methyl]-5-butoxy-2-[(3,4-difluorophenyl)methyl]-4-oxopentanamide;methane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R)-N-[(1-aminoisoquinolin-6-yl)methyl]-5-butoxy-2-[(3,4-difluorophenyl)methyl]-4-oxopentanamide;methane?
The IUPAC name of (2R)-N-[(1-aminoisoquinolin-6-yl)methyl]-5-butoxy-2-[(3,4-difluorophenyl)methyl]-4-oxopentanamide;methane (CID 167582278) is (2R)-N-[(1-aminoisoquinolin-6-yl)methyl]-5-butoxy-2-[(3,4-difluorophenyl)methyl]-4-oxopentanamide;methane.
What is the SMILES notation for (2R)-N-[(1-aminoisoquinolin-6-yl)methyl]-5-butoxy-2-[(3,4-difluorophenyl)methyl]-4-oxopentanamide;methane?
The canonical SMILES for (2R)-N-[(1-aminoisoquinolin-6-yl)methyl]-5-butoxy-2-[(3,4-difluorophenyl)methyl]-4-oxopentanamide;methane is C.CCCCOCC(=O)C[C@@H](Cc1ccc(F)c(F)c1)C(=O)NCc1ccc2c(N)nccc2c1.
What is the InChIKey of (2R)-N-[(1-aminoisoquinolin-6-yl)methyl]-5-butoxy-2-[(3,4-difluorophenyl)methyl]-4-oxopentanamide;methane?
The InChIKey is HIHXSGYAIBUSBK-VEIFNGETSA-N. The full InChI is InChI=1S/C26H29F2N3O3.CH4/c1-2-3-10-34-16-21(32)14-20(11-17-5-7-23(27)24(28)13-17)26(33)31-15-18-4-6-22-19(12-18)8-9-30-25(22)29;/h4-9,12-13,20H,2-3,10-11,14-16H2,1H3,(H2,29,30)(H,31,33);1H4/t20-;/m1./s1.
What are the key properties of (2R)-N-[(1-aminoisoquinolin-6-yl)methyl]-5-butoxy-2-[(3,4-difluorophenyl)methyl]-4-oxopentanamide;methane?
(2R)-N-[(1-aminoisoquinolin-6-yl)methyl]-5-butoxy-2-[(3,4-difluorophenyl)methyl]-4-oxopentanamide;methane has a molecular weight of 485.58 g/mol, XLogP of 4.98, 12 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-N-[(1-aminoisoquinolin-6-yl)methyl]-5-butoxy-2-[(3,4-difluorophenyl)methyl]-4-oxopentanamide;methane is sourced from PubChem (CID 167582278), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).